A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma

Summary

The objective of this Phase II trial is to compare the efficacy and safety of 6 months of treatment with thymalfasin plus trans arterial chemoembolization (TACE) with TACE alone in adult patients with non-surgical hepatocellular carcinoma (HCC).

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications